Gts Securities LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $2.87 Million - $3.36 Million	2,800 Added 31.82%	11,600 $12.2 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $3.89 Million - $4.71 Million	-4,400 Reduced 33.33%	8,800 $9.25 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $9.12 Million - $10 Million	-10,100 Reduced 43.35%	13,200 $12.7 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $465,107 - $529,020	-600 Reduced 2.51%	23,300 $20.5 Million
Q3 2023 Nov 15, 2023	BUY	$692.45 - $844.37 $16.5 Million - $20.2 Million	23,900 New	23,900 $19.7 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.